These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1704122)

  • 41. Induction and Partial purification of duck fibroblast interferon.
    Ziegler RE; Joklik WK
    Methods Enzymol; 1981; 78(Pt A):563-70. PubMed ID: 6173644
    [No Abstract]   [Full Text] [Related]  

  • 42. The physiological interferon response: IV. Production of interferon by the perfused human placenta at term.
    Bocci V; Paulesu L; Ricci MG
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):137-43. PubMed ID: 2412233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High sensitivity of C3H mouse embryo-derived cell line to the antiviral activity of interferon.
    Brouty-Boyé D
    Proc Soc Exp Biol Med; 1977 Jul; 155(3):438-9. PubMed ID: 195290
    [No Abstract]   [Full Text] [Related]  

  • 44. Circulating interferon in mice infected with the lactate dehydrogenase-elevating virus.
    Evans R; Riley V
    J Gen Virol; 1968 Dec; 3(3):449-52. PubMed ID: 4304104
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential inactivation and separation of homologous and heterologous antiviral activity of human leukocyte interferon by a proteolytic enzyme.
    Braude IA; Lin LS; Stewart WE
    Biochem Biophys Res Commun; 1979 Jul; 89(2):612-9. PubMed ID: 226088
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon activity and its characterization in the sera of patients with head and neck cancer.
    Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Furumoto N; Hayashi Y; Takegawa Y
    Cancer; 1984 Oct; 54(7):1239-51. PubMed ID: 6205740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification of interferon produced in a culture of human granulocytes.
    Hobb DS; Moschera JA; Levy WP; Pestka S
    Methods Enzymol; 1981; 78(Pt A):472-81. PubMed ID: 6173631
    [No Abstract]   [Full Text] [Related]  

  • 48. Interferon system in acute viral hepatitis.
    Levin S; Hahn T
    Lancet; 1982 Mar; 1(8272):592-4. PubMed ID: 6174836
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiviral activity in sera of patients with influenza infection.
    Bricout F; Nicolas JC; Huraux JM; Ingrand D
    Biomedicine; 1978 Oct; 29(6):198-200. PubMed ID: 737279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How useful are serum and CSF interferon levels as a rapid diagnostic aid in virus infections?
    Flowers D; Scott GM
    J Med Virol; 1985 Jan; 15(1):35-47. PubMed ID: 2578554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Protein adsorption at the tips from synthetic polymers as the cause of incorrect titer analysis of interferons in antiviral bioassays].
    Tonew M; Ohme E; Gerlach D; Wondraczek RH
    Z Med Lab Diagn; 1991; 32(2):108-13. PubMed ID: 1648851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of interferon and polyacrylic acid in newborn mice infected with a lethal dose of vesicular stomatitis virus.
    De Clercq E; De Somer P
    Life Sci; 1968 Sep; 7(17):925-33. PubMed ID: 4309814
    [No Abstract]   [Full Text] [Related]  

  • 53. Encapsulation of human fibroblast interferon activity in liposomes.
    Gurari-Rotman D; Lelkes PI
    Biochem Biophys Res Commun; 1982 Jul; 107(1):136-43. PubMed ID: 6181781
    [No Abstract]   [Full Text] [Related]  

  • 54. High affinity binding of 125I-Labeled mouse interferon to a specific cell surface receptor. II. Analysis of binding properties.
    Aguet M; Blanchard B
    Virology; 1981 Dec; 115(2):249-61. PubMed ID: 6171930
    [No Abstract]   [Full Text] [Related]  

  • 55. [Serum endogenous interferon indices in acute respiratory viral infections in young infants].
    Chobotar'ova VD; Povolots'kyi IaL; Korniienko AB; Kryvokhats'ka LD
    Pediatr Akus Ginekol; 1979; (6):15-7. PubMed ID: 534552
    [No Abstract]   [Full Text] [Related]  

  • 56. Measurement of interferon in human amniotic fluid and placental blood extract.
    Duc-Goiran P; Lebon P; Chany C
    Methods Enzymol; 1986; 119():541-51. PubMed ID: 2429155
    [No Abstract]   [Full Text] [Related]  

  • 57. [Concentration and antiviral activity of interferon-alpha in the sera of patient with hepatic pathology].
    Astakhin AV; Levitan BN; Afanas'ev SS; Vorob'ev AA; Aleshkin VA; Denisov LA; Chishieva EM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (1):59-62. PubMed ID: 15024984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the inhibition of interferon action by inhibitors of fatty acid cyclooxygenase.
    Sarkar FH; Gupta SL
    Virology; 1982 Dec; 123(2):448-51. PubMed ID: 6184880
    [No Abstract]   [Full Text] [Related]  

  • 59. Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity.
    Stewart WE; Desmyter J
    Virology; 1975 Sep; 67(1):68-73. PubMed ID: 170740
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of ascorbic acid, sodium salicylate, and caffeine on the serum interferon level in response to viral infection.
    Geber WF; Lefkowitz SS; Hung CY
    Pharmacology; 1975; 13(3):228-33. PubMed ID: 168598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.